Tumors can exploit these control pathways to evade the immune response, as a matter of fact, PD-L1 expression correlates with tumor size, grade, metastatic spread, as well as with reduced levels of CD8+ T cells [100, 101]. The gene discussed is CD274; the disease is neoplasm.